Sign in to view content

Dry AMD Symposium 2

Video
Published 2020

Related

Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of Great Than or Equal to 4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S
Allen Chiang, MD, FASRS
Annual Meeting Talks
2019
Evaluation of 8 mg Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Results from the Phase 2 CANDELA Study
W. Lloyd Clark, MD, FASRS
Updates from the Field
2022
Diabetic Retinopathy Take Home Panel
Annual Meeting Talks
2020

Category: AMD-Non-Neovascular

See more

Annual Meeting Talks